×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [8]
Institute of Chi... [5]
THE STATE KEY LA... [3]
Authors
TAM KIN YIP [3]
TAN KAELING [2]
CHEN XIN [1]
CHUXIA DENG [1]
KWOK HANG FAI [1]
POON CHUEN WAI [1]
More...
Document Type
Journal article [17]
Date Issued
2024 [1]
2023 [3]
2022 [3]
2021 [1]
2020 [2]
2019 [2]
More...
Language
英語English [15]
Source Publication
Acta Pharmaceuti... [2]
European Journal... [2]
BIOMATERIALS [1]
CANCER LETTERS [1]
Cancers [1]
Cell Journal [1]
More...
Indexed By
SCIE [15]
ESCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 17
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Antidepressant Sertraline Synergistically Enhances Paclitaxel Efficacy by Inducing Autophagy in Colorectal Cancer Cells
Journal article
He, Leping, Tian, Yuxi, Liu, Qingqing, Bao, Jiaolin, Ding, Ren Bo. Antidepressant Sertraline Synergistically Enhances Paclitaxel Efficacy by Inducing Autophagy in Colorectal Cancer Cells[J]. Molecules, 2024, 29(16), 3733.
Authors:
He, Leping
;
Tian, Yuxi
;
Liu, Qingqing
;
Bao, Jiaolin
;
Ding, Ren Bo
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
4.2
/
4.6
|
Submit date:2024/10/10
Autophagy
Colorectal Cancer
Drug Combination
Paclitaxel
Sertraline
Epigallocatechin gallate circumvents drug induced resistance in non-small cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis
Journal article
Zhou, Yan, Huang, Shiqi, Guo, Yizhen, Ran, Maxoin, Shan, Wenying, Wen-Hau Chen, Tam, Kin Yip. Epigallocatechin gallate circumvents drug induced resistance in non-small cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis[J]. Phytotheraphy Research, 2023, 37(12), 5837-5853.
Authors:
Zhou, Yan
;
Huang, Shiqi
;
Guo, Yizhen
;
Ran, Maxoin
;
Shan, Wenying
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
7
IF:
6.1
/
7.0
|
Submit date:2023/08/22
Acquired Drug Resistance
Combination Therapy
Egcg
Egfr-tkis
Nsclc
Synergetic Effect
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:
Zhou,Jing Bo
;
Tang,Dongyang
;
He,Lin
;
Lin,Shiqi
;
Lei,Josh Haipeng
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
9.1
/
9.0
|
Submit date:2023/08/03
Bortezomib (Pubchem Cid: 387447)
Cepharanthine (Pubchem Cid: 10206)
Docetaxel (Taxotere) (Pubchem Cid: 11970251)
Drug Combination Therapy
Flunarizine Dihydrochloride (Pubchem Cid: 5282407)
Lapatinib Ditosylate (Pubchem Cid: 9941095)
Machine Learning
Pazopanib Hydrochloride (Pubchem Cid: 11525740)
Potential Combination Biomarkers
Tamoxifen Citrate (Pubchem Cid: 2733525)
Three-dimensional Tumor Slice Culture
Vatalanib (Pubchem Cid: 151194)
Vincristine (Pubchem Cid: 5978)
Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)
Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy
Journal article
Li, Qiuxia, Liu, Xing, Yan, Chunmei, Zhao, Bolin, Zhao, Yuxin, Yang, Lu, Shi, Mingyi, Yu, Hua, Li, Xiaofang, Luo, Kaipei. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy[J]. Small, 2023, 19(23), 2206211.
Authors:
Li, Qiuxia
;
Liu, Xing
;
Yan, Chunmei
;
Zhao, Bolin
;
Zhao, Yuxin
; et al.
Favorite
|
TC[WOS]:
28
TC[Scopus]:
29
IF:
13.0
/
13.5
|
Submit date:2023/07/20
Anticancer Efficacy
Combination Cancer Immunotherapy
Drug Delivery
Polysaccharide
Stimulus-responsive Nanomedicines
The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis
Journal article
Liang, Zimao, Xie, Han, Shen, Weixing, Shao, Le, Zeng, Li, Huang, Xingxing, Zhu, Qianru, Zhai, Xiangyang, Li, Keshuai, Qiu, Zejing, Sui, Xinbing, Cheng, Haibo, Wu, Qibiao. The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis[J]. Frontiers in Bioscience - Landmark, 2022, 27(9).
Authors:
Liang, Zimao
;
Xie, Han
;
Shen, Weixing
;
Shao, Le
;
Zeng, Li
; et al.
Favorite
|
TC[WOS]:
17
TC[Scopus]:
16
IF:
3.3
/
3.6
|
Submit date:2023/01/30
Colorectal Cancer
Conventional Therapeutics
Drug Combination
Natural Compounds
Progression And Metastasis
Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection
Journal article
He, Xueqin, Wang, Xiaorong, Yang, Lianyi, Yang, Zhihang, Yu, Wenqi, Wang, Yazhen, Liu, Rui, Chen, Meiwan, Gao, Huile. Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection[J]. Acta Pharmaceutica Sinica B, 2022, 12(4), 1987-1999.
Authors:
He, Xueqin
;
Wang, Xiaorong
;
Yang, Lianyi
;
Yang, Zhihang
;
Yu, Wenqi
; et al.
Favorite
|
TC[WOS]:
41
TC[Scopus]:
42
IF:
14.7
/
14.1
|
Submit date:2022/05/13
Alzheimer's Disease
Anti-neuroinflammation
Blood‒brain Barrier Transcytosis
Drug Combination
Nano Drug Delivery System
Neuroprotection
Receptor For Advanced Glycation End Products
Ros-responsive
Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer’s disease treatment by anti-neuroinflammation and neuroprotection
Journal article
He, Xueqin, Wang, Xiaorong, Yang, Lianyi, Yang, Zhihang, Yu, Wenqi, Wang, Yazhen, Liu, Rui, Chen, Meiwan, Gao, Huile. Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer’s disease treatment by anti-neuroinflammation and neuroprotection[J]. Acta Pharmaceutica Sinica B, 2022, 12(4), 1987-1999.
Authors:
He, Xueqin
;
Wang, Xiaorong
;
Yang, Lianyi
;
Yang, Zhihang
;
Yu, Wenqi
; et al.
Favorite
|
TC[WOS]:
41
TC[Scopus]:
42
IF:
14.7
/
14.1
|
Submit date:2022/08/29
Receptor For Advanced Glycation End Products
Ros-responsive
Blood‒brain Barrier Transcytosis
Alzheimer's Disease
Drug Combination
Anti-neuroinflammation
Neuroprotection
Nano Drug Delivery System
Natural Products in Cancer Therapy: Past, Present and Future
Journal article
Huang,Min, Lu,Jin Jian, Ding,Jian. Natural Products in Cancer Therapy: Past, Present and Future[J]. Natural Products and Bioprospecting, 2021, 11(1), 5-13.
Authors:
Huang,Min
;
Lu,Jin Jian
;
Ding,Jian
Favorite
|
TC[WOS]:
322
TC[Scopus]:
333
IF:
4.8
/
3.9
|
Submit date:2021/03/02
Antibody–drug Conjugates
Cancer Therapy
Combination Therapy
Drug Discovery
Natural Products
A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets
Journal article
Zhou,Peng, Chan,Becky K.C., Wan,Yuk Kei, Yuen,Chaya T.L., Choi,Gigi C.G., Li,Xinran, Tong,Cindy S.W., Zhong,Sophia S.W., Sun,Jieran, Bao,Yufan, Mak,Silvia Y.L., Chow,Maggie Z.Y., Khaw,Jien Vei, Leung,Suet Yi, Zheng,Zongli, Cheung,Lydia W.T., Tan,Kaeling, Wong,Koon Ho, Chan,H. Y.Edwin, Wong,Alan S.L.. A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets[J]. Cell Reports, 2020, 32(6), 108020.
Authors:
Zhou,Peng
;
Chan,Becky K.C.
;
Wan,Yuk Kei
;
Yuen,Chaya T.L.
;
Choi,Gigi C.G.
; et al.
Favorite
|
TC[WOS]:
25
TC[Scopus]:
26
IF:
7.5
/
8.5
|
Submit date:2021/03/04
Cancer
Combigem
Combination Therapy
Combinatorial Genetics
Crispr
Drug Interaction
Genetic Interaction
High-throughput Screening
Neurodegeneration
Parkinson's Disease
Current strategies for treating NSCLC: From biological mechanisms to clinical treatment
Journal article
Li,Junnan, Kwok,Hang Fai. Current strategies for treating NSCLC: From biological mechanisms to clinical treatment[J]. Cancers, 2020, 12(6), 1587.
Authors:
Li,Junnan
;
Kwok,Hang Fai
Favorite
|
TC[WOS]:
27
TC[Scopus]:
28
IF:
4.5
/
4.9
|
Submit date:2021/03/04
Combination Targeted Therapy
Drug Resistance Mechanism
Egfr Mutation
Lung Cancer